Plasmapheresis treatment in COVID-19-related autoimmune meningoencephalitis: Case series

Simple item page
dc.contributor.authorDogan, Lerzan
dc.contributor.authorKaya, Dilaver
dc.contributor.authorSarikaya, Tugce
dc.contributor.authorZengin, Rehile
dc.contributor.authorDincer, Alp
dc.contributor.authorAkinci, Ibrahim Ozkan
dc.contributor.authorAfsar, Nazire
dc.date.accessioned2023-02-21T12:32:19Z
dc.date.available2023-02-21T12:32:19Z
dc.date.issued2020-01-01
dc.description.abstractSevere SARS-CoV-2 (COVID-19) infection has the potential for a high mortality rate. In this paper, we report the results of plasmapheresis treatment in a series of severely ill patients with COVID-19-related autoimmune meningoencephalitis in the Intensive Care Unit (ICU).
dc.description.issueJUL
dc.description.pages155-158
dc.description.volume87
dc.identifier.doi10.1016/j.bbi.2020.05.022
dc.identifier.urihttps://hdl.handle.net/11443/981
dc.identifier.urihttp://dx.doi.org/10.1016/j.bbi.2020.05.022
dc.identifier.wosWOS:000542965400055
dc.publisherACADEMIC PRESS INC ELSEVIER SCIENCE
dc.relation.ispartofBRAIN BEHAVIOR AND IMMUNITY
dc.subjectAutoimmune
dc.subjectEncephalitis
dc.subjectCOVID-19
dc.subjectPlasmapheresis
dc.titlePlasmapheresis treatment in COVID-19-related autoimmune meningoencephalitis: Case series
dc.typeArticle

Files

Original bundle

Now showing 1 - 1 of 1
Thumbnail Image
Name:
Plasmapheresis treatment in COVID-19-related autoimmune meningoencephalitis Case series.pdf
Size:
744.7 KB
Format:
Adobe Portable Document Format
Download

Collections

WOS